Industry-sponsored clinical drug trials in Egypt

Geplaatst in categorie:

Publicatie

Geschreven door:

Geschreven door: Irene Schipper

Geschreven door: A. den Boer

Geschreven door: P. Durisch

Geschreven door: A. Kohli

Gepubliceerd op: 21 juni 2016

When engaging in clinical trials in low- and middle-income countries with limited access to treatment, pharmaceutical companies should ascertain that the safety and rights of participants are properly protected and that their practice are in line with the highest ethical standards. They should also make sure that the medications tested in those countries are available at an affordable price. This study brings new evidence that unethical practices occur in TNC sponsored clinical trials conducted in Egypt, and that drugs tested in Egypt are not systematically available to and mostly unaffordable for the Egyptian population.

Geplaatst in categorie:

Publicatie

Geschreven door:

Geschreven door: Irene Schipper

Geschreven door: A. den Boer

Geschreven door: P. Durisch

Geschreven door: A. Kohli

Gepubliceerd op: 21 juni 2016